Insights
News & Insights
Practical notes on regulation, quality systems, clinical operations, and life sciences consulting.
Archive
More articles
483 Warning Letters & How to Resolve Them
What an FDA 483 Warning Letter is, and how to work through the findings behind it.
Read article3D Printing of Medical Devices
How 3D printing met urgent PPE demand during COVID-19, and what that means for medical device regulation.
Read articleCompounding, Outsourcing Facilities, Current Good Manufacturing
How compounded drugs and outsourcing facilities are regulated under federal manufacturing rules.
Read articleFDA Oversight for Medical Devices: Insight into Regulatory Process
How the FDA regulates medical devices from development through commercial use.
Read articlePharmacovigilance, Then and Now
How pharmacovigilance grew from early ADR reports into today's clinical and post-market safety work.
Read articleLooking for applied expertise?
Reading is one thing; acting is another. Our team can help turn a regulatory or quality question into a plan.